Brief: Quest PharmaTech to acquire 32% of Natural Rf Life Sciences common stock
04/05/2017 16:34
May 4 (Reuters) - Quest PharmaTech Inc QPT.V :
* Says making a $500,000 cash investment to acquire 32% of
outstanding common stock of Natural Rf Life Sciences Inc
Source text for Eikon: ID:nPn2VMz1Sa
Further company coverage: QPT.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Quest PharmaTech
See all newsBrief: Quest Pharmatech Announces Change Of Chief Executive Officer
Brief: Quest Pharmatech Provides Product Development Update
Brief: Quest PharmaTech Clarifies Agreement in Principle with OQP Bio
Brief: Quest Pharmatech Provides Corporate Update
Brief: Quest PharmaTech Announces Sale Of Bioceltran Investment And Return Of Photodynamic Therapy Technology License